Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 919 $ 876
Restricted cash 1,590 860
Accounts and other receivables 264 218
Accounts receivable—related party 1 0
Inventory 133 160
Derivative assets 12 24
Other current assets 112 100
Total current assets 3,031 2,238
Non-current restricted cash 66 91
Property, plant and equipment, net 23,466 20,635
Debt issuance costs, net 159 277
Non-current derivative assets 37 83
Goodwill 77 77
Other non-current assets, net 298 302
Total assets 27,134 23,703
Current liabilities    
Accounts payable 59 49
Accrued liabilities 722 637
Current debt 41 247
Deferred revenue 134 73
Derivative liabilities 55 71
Total current liabilities 1,011 1,077
Long-term debt, net 24,923 21,688
Non-current deferred revenue 2 5
Non-current derivative liabilities 52 45
Other non-current liabilities 63 49
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at September 30, 2017 and December 31, 2016; Issued: 250.1 million shares at September 30, 2017 and December 31, 2016
Outstanding: 237.8 million shares and 238.0 million shares at September 30, 2017 and December 31, 2016, respectively 1 1
Treasury stock: 12.3 million shares and 12.2 million shares at September 30, 2017 and December 31, 2016, respectively, at cost (378) (374)
Additional paid-in-capital 3,238 3,211
Accumulated deficit (4,754) (4,234)
Total stockholders’ deficit (1,893) (1,396)
Non-controlling interest 2,976 2,235
Total equity 1,083 839
Total liabilities and equity $ 27,134 $ 23,703